Vistin Pharma ASA VISTN

OSL: VISTN | ISIN: NO0010734122   23/12/2024
23,70 NOK (-2,87%)
(-2,87%)   23/12/2024

6 november 2024 · Ex dividend NOK 0.50 today · Persbericht

31 oktober 2024 · Vistin Pharma ASA: Third quarter and YTD 2024 financial results · Persbericht

24 oktober 2024 · Vistin Pharma ASA: Invitation to Q3 2024 conference call · Persbericht

21 oktober 2024 · Responsibility statement for first half year of 2024 · Persbericht

26 september 2024 · Vistin Pharma ASA: Mandatory notification of trade · Persbericht

13 september 2024 · Disclosure of large shareholding and mandatory notification of trade in Vistin Pharma ASA · Persbericht

23 augustus 2024 · Vistin Pharma ASA: Mandatory notification of trade · Persbericht

23 augustus 2024 · Vistin Pharma ASA: Second quarter and first half 2024 financial results · Persbericht

16 augustus 2024 · Vistin Pharma ASA: Invitation to Q2 2024 conference call · Persbericht

5 juni 2024 · Ex dividend NOK 0.50 today · Persbericht

23 mei 2024 · Vistin Pharma ASA: Minutes from the annual general meeting 2024 · Persbericht

23 mei 2024 · Disclosure of voting rights at AGM in Vistin Pharma ASA · Persbericht

30 april 2024 · Vistin Pharma ASA: Notice of Annual General Meeting 23 May 2024 · Persbericht

24 april 2024 · Vistin Pharma ASA: Annual Report 2023 · Persbericht

24 april 2024 · Vistin Pharma ASA: First quarter 2024 financial results · Persbericht

16 april 2024 · Vistin Pharma ASA: Invitation to Q1 2024 conference call · Persbericht

22 maart 2024 · Vistin Pharma ASA: Mandatory notification of trade · Persbericht

4 maart 2024 · Vistin Pharma ASA (VISTN) acquires minority share in CF Pharma (Hungary) · Persbericht

16 februari 2024 · Vistin Pharma ASA: Key information relating to the proposed cash dividend · Persbericht

16 februari 2024 · Vistin Pharma ASA: Fourth quarter and preliminary 2023 financial results · Persbericht

Mijn selecties